Advaxis Inc reports results for the quarter ended in July - Earnings Summary

Ayala Pharmaceuticals

10/09/2021 12:27

* Advaxis Inc  ADXS.OQ  reported a quarterly adjusted loss of 2
cents​​ per share for the quarter ended in July. The lone
analyst forecast for the quarter was for a loss of 4 cents per
share.
* Revenue was $250.00 thousand​;  analysts expected zero. 
* Advaxis Inc's reported EPS for the quarter was a loss of 2
cents​.
* The mean earnings estimate of analysts was unchanged in the
last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Advaxis Inc shares had risen by 1.0% this quarter and
gained 34.3% so far this year.
* The company reported a quarterly loss of $3.33 million.
* Wall Street's median 12-month price target for Advaxis Inc is
$2.25 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 1 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
This summary was machine generated September 10 at 11:27 a.m.
 ​All figures in US dollars unless otherwise stated